Mannkind (MNKD) Return on Sales (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 96.00 |
| Jun 30, 2022 | -95.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -2.00 |
| Sep 30, 2021 | 1.00 |
| Jun 30, 2021 | -1.00 |
| Mar 31, 2021 | 1.00 |
| Dec 31, 2020 | -1.00 |
| Sep 30, 2020 | 51.00 |
| Jun 30, 2020 | -51.00 |
| Mar 31, 2020 | 0.00 |
| Dec 31, 2019 | 14.00 |
| Sep 30, 2019 | 47.00 |
| Jun 30, 2019 | -61.00 |
| Mar 31, 2019 | 0.00 |
| Dec 31, 2018 | 5.00 |
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 3.00 |
| Mar 31, 2018 | -27.00 |
| Dec 31, 2017 | 34.00 |
| Sep 30, 2017 | 0.00 |
| Jun 30, 2017 | -11.00 |
| Mar 31, 2017 | -10.00 |
| Dec 31, 2016 | 4.00 |
| Jun 30, 2014 | -778.00 |
| Dec 31, 2012 | -3,615.00 |
| Dec 31, 2011 | 38.00 |
| Sep 30, 2011 | 138.00 |
| Jun 30, 2011 | -2,562.00 |